Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 98
of 5Next
1:

Does higher cost mean better quality? evidence from highly-regarded adolescent drug treatment programs.

Schackman BR, Rojas EG, Gans J, Falco M, Millman RB.

Subst Abuse Treat Prev Policy. 2007 Jul 31;2:23.

PMID: 17672900 [PubMed - in process]

2:

The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey.

Brannigan R, Schackman BR, Falco M, Millman RB.

Arch Pediatr Adolesc Med. 2004 Sep;158(9):904-9.

PMID: 15351757 [PubMed - indexed for MEDLINE]

3:

Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.

Burdon WM, Dang J, Prendergast ML, Messina NP, Farabee D.

Subst Abuse Treat Prev Policy. 2007 May 15;2:16.

PMID: 17504540 [PubMed]

4:

Costs of day hospital and community residential chemical dependency treatment.

Kaskutas LA, Zavala SK, Parthasarathy S, Witbrodt J.

J Ment Health Policy Econ. 2008 Mar;11(1):27-32.

PMID: 18424874 [PubMed - indexed for MEDLINE]

5:

Differences in the cost of antidepressants across state Medicaid programs.

Kelton CM, Rebelein RP, Heaton PC, Ferrand Y, Guo JJ.

J Ment Health Policy Econ. 2008 Mar;11(1):33-47.

PMID: 18424875 [PubMed - indexed for MEDLINE]

6:

Adolescent-only substance abuse treatment: Availability and adoption of components of quality.

Knudsen HK.

J Subst Abuse Treat. 2008 Nov 10. [Epub ahead of print]

PMID: 19000942 [PubMed - as supplied by publisher]

7:

Factors that influence staffing of outpatient substance abuse treatment programs.

Lemak CH, Alexander JA.

Psychiatr Serv. 2005 Aug;56(8):934-9.

PMID: 16088009 [PubMed - indexed for MEDLINE]

8:

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID: 17999840 [PubMed - indexed for MEDLINE]

9:

Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.

Yeom HS, Shepard DS.

J Ment Health Policy Econ. 2007 Dec;10(4):207-19.

PMID: 18166831 [PubMed - indexed for MEDLINE]

10:

Does state certification or licensure influence outpatient substance abuse treatment program practices?

Chriqui JF, Terry-McElrath Y, McBride DC, Eidson SS, VanderWaal CJ.

J Behav Health Serv Res. 2007 Jul;34(3):309-28. Epub 2007 Jun 26.

PMID: 17592782 [PubMed - indexed for MEDLINE]

11:

Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL; Cost Subcommittee of the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study Group.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):449-58.

PMID: 18197121 [PubMed - indexed for MEDLINE]

12:

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

PMID: 18485271 [PubMed - indexed for MEDLINE]

14:

Uninsurance among children whose parents are losing Medicaid coverage: Results from a statewide survey of Oregon families.

DeVoe JE, Krois L, Edlund T, Smith J, Carlson NE.

Health Serv Res. 2008 Feb;43(1 Pt 2):401-18.

PMID: 18199193 [PubMed - indexed for MEDLINE]

15:

State policies matter: the case of outpatient drug treatment program practices.

Chriqui JF, Terry-McElrath Y, McBride DC, Eidson SS.

J Subst Abuse Treat. 2008 Jul;35(1):13-21. Epub 2007 Oct 23.

PMID: 17936550 [PubMed - indexed for MEDLINE]

16:

The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada.

Sanyal C, Graham SD, Cooke C, Sketris I, Frail DM, Flowerdew G.

BMC Health Serv Res. 2008 May 24;8:111.

PMID: 18501012 [PubMed - indexed for MEDLINE]

17:

Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups.

Nordentoft M.

Dan Med Bull. 2007 Nov;54(4):306-69. Review.

PMID: 18208680 [PubMed - indexed for MEDLINE]

18:

Insurance coverage and incentives for weight loss among adults with metabolic syndrome.

Arterburn D, Westbrook EO, Wiese CJ, Ludman EJ, Grossman DC, Fishman PA, Finkelstein EA, Jeffery RW, Drewnowski A.

Obesity (Silver Spring). 2008 Jan;16(1):70-6.

PMID: 18223615 [PubMed - indexed for MEDLINE]

19:

Role of health insurance coverage in women's access to prescription medicines.

Ranji UR, Wyn R, Salganicoff A, Yu H.

Womens Health Issues. 2007 Nov-Dec;17(6):360-6.

PMID: 18042485 [PubMed - indexed for MEDLINE]

20:

Examining quality improvement programs: the case of Minnesota hospitals.

Olson JR, Belohlav JA, Cook LS, Hays JM.

Health Serv Res. 2008 Oct;43(5 Pt 2):1787-806. Epub 2008 Aug 29.

PMID: 18761677 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 98
of 5Next